rhodioloside has been researched along with Invasiveness, Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pingping, H; Qinglin, H; Shangzhu, L; Yuetong, L | 1 |
| Joung, YH; Kang, DY; Kim, DH; Lee, HG; Park, YM; Sp, N; Yang, YM | 1 |
| Hang, S; Huang, D; Li, H | 1 |
| Ren, M; Xu, T; Xu, W | 1 |
| Chen, X; Kou, Y; Lu, Y; Pu, Y | 1 |
| Sun, C; Wang, Z; Zhang, H; Zheng, Q | 1 |
6 other study(ies) available for rhodioloside and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Salidroside inhibits proliferation, migration and invasion of human pancreatic cancer PANC1 and SW1990 cells through the AKT and ERK signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Glucosides; Humans; MAP Kinase Signaling System; Neoplasm Invasiveness; Pancreatic Neoplasms; Phenols; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Survival; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phenols; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2018 |
RETRACTED: Salidroside inhibits the growth, migration and invasion of Wilms' tumor cells through down-regulation of miR-891b.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Glucosides; Humans; MicroRNAs; Neoplasm Invasiveness; Phenols; Wilms Tumor | 2019 |
Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glucosides; Humans; Lung Neoplasms; MAP Kinase Signaling System; MicroRNAs; Neoplasm Invasiveness; Phenols; Proto-Oncogene Proteins c-akt; Up-Regulation | 2019 |
Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2.
Topics: Amino Acid Oxidoreductases; Animals; Antineoplastic Agents; Cadherins; Carcinogenesis; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disulfides; Down-Regulation; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Pancreatic Neoplasms; Phenols; Sulfonamides | 2020 |
Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells.
Topics: Antineoplastic Agents, Phytogenic; Cadherins; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Fibrosarcoma; Glucosides; Humans; Integrin beta1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phenols; Phosphorylation; Protease Inhibitors; Reactive Oxygen Species; Rhodiola | 2012 |